Busey Wealth Management Novartis Ag Transaction History

Busey Wealth Management

$2.99 Billion
Q4 2024

A detailed history of Busey Wealth Management transactions in Novartis Ag stock. As of the latest transaction made, Busey Wealth Management holds 2,850 shares of NVS stock, worth $304,693. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,850

Previous 2,856 0.21%

Holding current value

$304,693

Previous $328,000 15.55%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 23, 2025	SELL	$96.78 - $117.18 $580 - $703	-6 Reduced 0.21%	2,850 $277,000
Q3 2024 Oct 23, 2024	SELL	$106.13 - $120.89 $91,377 - $104,086	-861 Reduced 23.16%	2,856 $328,000
Q2 2024 Jul 23, 2024	SELL	$92.57 - $107.37 $39,064 - $45,310	-422 Reduced 10.2%	3,717 $395,000
Q1 2024 Apr 23, 2024	BUY	$95.27 - $108.47 $20,292 - $23,104	213 Added 5.43%	4,139 $400,000
Q4 2023 Jan 25, 2024	BUY	$92.27 - $101.54 $29,526 - $32,492	320 Added 8.87%	3,926 $396,000
Q3 2023 Oct 23, 2023	SELL	$94.73 - $105.13 $66,974 - $74,326	-707 Reduced 16.39%	3,606 $367,000
Q2 2023 Jul 21, 2023	SELL	$92.52 - $104.91 $27,756 - $31,473	-300 Reduced 6.5%	4,313 $435,000
Q1 2023 Apr 25, 2023	SELL	$80.03 - $92.81 $1,440 - $1,670	-18 Reduced 0.39%	4,613 $424,000
Q4 2022 Jan 23, 2023	SELL	$75.55 - $92.52 $2,644 - $3,238	-35 Reduced 0.75%	4,631 $0
Q3 2022 Oct 24, 2022	SELL	$74.61 - $87.26 $9,550 - $11,169	-128 Reduced 2.67%	4,666 $355,000
Q2 2022 Aug 01, 2022	BUY	$80.52 - $93.75 $1,449 - $1,687	18 Added 0.38%	4,794 $405,000
Q1 2022 Apr 21, 2022	SELL	$80.11 - $90.62 $47,505 - $53,737	-593 Reduced 11.04%	4,776 $420,000
Q4 2021 Jan 25, 2022	SELL	$79.7 - $88.13 $20,243 - $22,385	-254 Reduced 4.52%	5,369 $470,000
Q3 2021 Oct 29, 2021	BUY	$81.78 - $95.14 $70,903 - $82,486	867 Added 18.23%	5,623 $460,000
Q2 2021 Jul 22, 2021	SELL	$85.24 - $94.15 $4,006 - $4,425	-47 Reduced 0.98%	4,756 $433,000
Q1 2021 Apr 20, 2021	SELL	$83.5 - $98.47 $31,730 - $37,418	-380 Reduced 7.33%	4,803 $411,000
Q4 2020 Jan 20, 2021	SELL	$78.07 - $94.43 $181,122 - $219,077	-2,320 Reduced 30.92%	5,183 $490,000
Q3 2020 Oct 16, 2020	SELL	$82.14 - $91.0 $5,831 - $6,461	-71 Reduced 0.94%	7,503 $653,000
Q2 2020 Jul 21, 2020	SELL	$80.93 - $91.1 $67,819 - $76,341	-838 Reduced 9.96%	7,574 $662,000
Q1 2020 Apr 17, 2020	SELL	$70.67 - $99.01 $1,484 - $2,079	-21 Reduced 0.25%	8,412 $694,000
Q4 2019 Feb 11, 2020	BUY	$84.35 - $95.37 $122,307 - $138,286	1,450 Added 20.76%	8,433 $798,000
Q3 2019 Nov 12, 2019	BUY	$85.54 - $94.26 $397,589 - $438,120	4,648 Added 199.06%	6,983 $607,000
Q2 2019 Jul 24, 2019	SELL	$75.4 - $92.8 $980 - $1,206	-13 Reduced 0.55%	2,335 $214,000
Q1 2019 Apr 16, 2019	BUY	$75.32 - $86.15 $176,851 - $202,280	2,348 New	2,348 $225,000
Q1 2018 May 04, 2018	SELL	$70.39 - $84.15 $170,977 - $204,400	-2,429 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$72.33 - $77.64 $175,689 - $188,587	2,429	2,429 $204,000

Others Institutions Holding NVS

# of Institutions

1,472

Shares Held

134M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $230B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Busey Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Busey Wealth Management with notifications on news.

Account

Busey Wealth Management Novartis Ag Transaction History